NCT00180050View on ClinicalTrials.gov

Budesonide Treatment for Lymphocytic Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2007

Conditions
Microscopic Colitis
Interventions
DRUG

Budesonide

Trial Locations (1)

01307

Medical Department I, Technical University Hospital, Dresden

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH
All Listed Sponsors
collaborator

Dr. Falk Pharma GmbH

INDUSTRY

lead

Technische Universität Dresden

OTHER